Personalis Inc (PSNL)

Dec 17, 2025

Personalis study shows cancer blood test predicts immunotherapy outcomes By Investing.com - Investing.com Nigeria

Dec 17, 2025

Dec 17, 2025

Personalis announces new publication applying ultrasensitive ctDNA testing - marketscreener.com

Dec 17, 2025

Dec 17, 2025

Personalis study shows cancer blood test predicts immunotherapy outcomes - Investing.com India

Dec 17, 2025

Dec 17, 2025

Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors - Business Wire

Dec 17, 2025

Dec 14, 2025

Personalis (NASDAQ:PSNL) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat

Dec 14, 2025

Dec 13, 2025

Personalis (NASDAQ:PSNL) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat

Dec 13, 2025

Dec 11, 2025

New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer - Business Wire

Dec 11, 2025

Dec 10, 2025

What AI ML Trends Might Elevate Afcons Infrastructure Limiteds Stock ProspectsDividend Yield Trends & Free Dynamic Investment Techniques - earlytimes.in

Dec 10, 2025

Dec 10, 2025

Why Analysts See Personalis Story Shifting With Medicare Tailwinds And Biopharma Headwinds - Yahoo Finance

Dec 10, 2025

Dec 10, 2025

Personalis, Inc. $PSNL Shares Purchased by Blue Water Life Science Advisors LP - MarketBeat

Dec 10, 2025

Dec 07, 2025

Personalis, Inc. (NASDAQ:PSNL) Stocks Shoot Up 38% But Its P/S Still Looks Reasonable - 富途牛牛

Dec 07, 2025

Dec 06, 2025

Personalis (NASDAQ:PSNL) Stock Price Down 4.8%What's Next? - MarketBeat

Dec 06, 2025

Dec 06, 2025

Personalis Outpaces The Market With Cancer Test Breakthroughs - Finimize

Dec 06, 2025

Dec 06, 2025

Personalis (NASDAQ:PSNL) Cut to Sell at Wall Street Zen - MarketBeat

Dec 06, 2025

Dec 05, 2025

Is Personalis Inc. (04X) stock undervalued by metricsEarnings Miss & Short-Term High Return Strategies - Newser

Dec 05, 2025

Dec 05, 2025

Geode Capital Management LLC Buys 851,422 Shares of Personalis, Inc. $PSNL - MarketBeat

Dec 05, 2025

Dec 05, 2025

Will Personalis Inc. (04X) stock maintain strong growthWeekly Volume Report & Growth Focused Investment Plans - Newser

Dec 05, 2025

Dec 04, 2025

Will Personalis Inc. (04X) stock beat Nasdaq index returns2025 Short Interest & Real-Time Volume Spike Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Will Personalis Inc. (04X) stock outperform Dow JonesMarket Risk Summary & Fast Moving Market Watchlists - Newser

Dec 03, 2025

Dec 03, 2025

How Personalis Inc. stock performs during Fed tightening cycles2025 Growth vs Value & Weekly Chart Analysis and Trade Guides - Newser

Dec 03, 2025

Dec 03, 2025

Will Personalis Inc. stock reach Wall Street targetsInsider Selling & Free Expert Verified Stock Movement Alerts - Newser

Dec 03, 2025

Dec 02, 2025

Personalis (PSNL) Rating Maintained and Price Target Raised by M - GuruFocus

Dec 02, 2025

Dec 02, 2025

Personalis (NASDAQ:PSNL) Shares Gap Down After Insider Selling - MarketBeat

Dec 02, 2025

Dec 02, 2025

Personalis, Inc. (NASDAQ:PSNL) Q2 2025 Earnings Call Transcript - MSN

Dec 02, 2025

Dec 02, 2025

Morgan Stanley Raises Price Target on Personalis to $11 From $9, Keeps Equalweight Rating - marketscreener.com

Dec 02, 2025

Dec 01, 2025

Piper Sandler Healthcare Conference - MarketScreener

Dec 01, 2025

Dec 01, 2025

Personalis, Inc. (NASDAQ:PSNL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Dec 01, 2025

Nov 29, 2025

Personalis Announces $100M Stock Offering Amendment - The Globe and Mail

Nov 29, 2025

Nov 29, 2025

Insider Selling: Personalis (NASDAQ:PSNL) CFO Sells 103,668 Shares of Stock - MarketBeat

Nov 29, 2025

Nov 28, 2025

Personalis files prospectus supplement for up to $100 million stock offering - Investing.com Nigeria

Nov 28, 2025

Nov 28, 2025

Personalis files prospectus supplement for up to $100 million stock offering By Investing.com - Investing.com South Africa

Nov 28, 2025

Nov 28, 2025

Personalis, Inc. Announces $100 Million Stock Offering - TradingView

Nov 28, 2025

Nov 28, 2025

Personalis CFO and COO Aaron Tachibana Sells Over 100K Shares - TradingView

Nov 28, 2025

Nov 28, 2025

COO Tachibana Sells 103,668 ($1.1M) Of Personalis Inc [PSNL] - TradingView

Nov 28, 2025

Nov 28, 2025

Insiders Of Personalis Make A Tidy Sum Selling At US$7.14 - simplywall.st

Nov 28, 2025

Nov 27, 2025

Personalis Stock: A Growth Inflection Is Imminent (NASDAQ:PSNL) - Seeking Alpha

Nov 27, 2025

Nov 26, 2025

Personalis (NASDAQ:PSNL) Hits New 12-Month HighHere's What Happened - MarketBeat

Nov 26, 2025

Nov 26, 2025

Personalis Stock Jump Looks Great, But How Secure Is That Gain? - Trefis

Nov 26, 2025

Nov 25, 2025

COO Tachibana Files To Sell 103,668 Of Personalis Inc [PSNL] - TradingView

Nov 25, 2025

Nov 25, 2025

Personalis says CMS revises reimbursement rate for Personal test for post-treatment surveillance of cancers - marketscreener.com

Nov 25, 2025

Nov 25, 2025

Personalis Says CMS Revises Reimbursement Rate For Personal Test For Post-Treatment Surveillance Of Cancers - TradingView

Nov 25, 2025

Nov 25, 2025

Personalis receives updated Medicare reimbursement rates for cancer monitoring tests - Investing.com India

Nov 25, 2025

Nov 25, 2025

Personalis, Inc. Announces Revised Medicare Reimbursement Rates - TradingView

Nov 25, 2025

Nov 25, 2025

[8-K] Personalis, Inc. Reports Material Event | PSNL SEC FilingForm 8-K - Stock Titan

Nov 25, 2025

Nov 24, 2025

How Analyst Views Are Shifting as Personalis Transforms Its Growth Story - Yahoo Finance

Nov 24, 2025

Nov 24, 2025

Personalis Inc buy BiotechBee - sharewise.com

Nov 24, 2025